Pharmacist.com

Image

 

Focus:

APhA DrugInfoLine is a monthly newsletter of interpreted drug and pharmacotherapeutic information designed to keep frontline pharmacists up-to-date on the latest trends in the biomedical literature. It includes regular coverage of these areas:

 * Cardiology  * Psychiatry  * HIV Care
 * Endocrinology  * Pulmonology  * Immunizations
 * Gastroenterology  * Rheumatology  * Lipids Management
 * Infectious Diseases  * Anticoagulation Care  * Alternative Medicines
 * Neurology  * Asthma Care  * OTC Medications
 * Oncology  * Diabetes Care  * Drug Interactions

APhA is the nation's largest professional association of pharmacists and is one of the oldest societies for health care professionals in the United States. The Association is a leader in providing timely, high-quality information and education for health care professionals, and is an advocate for improved health through the provision of comprehensive pharmaceutical care.

Image Circulation:
APhA DrugInfoLine is published monthly by APhA. APhA members who pay annual dues of $216 receive APhA DrugInfoLine as a benefit of membership; subscriptions are not available. Of this dues amount, $20 applies toward a subscription to APhA DrugInfoLine. For information about membership, to join, or to correct address information go to the membership section. You may also contact APhA at 800-237-APhA or by e-mail at infocenter@aphanet.org. Members should notify APhA and the U.S. Postal Service of changes of address.

›› Click for members only access to current and back issues of APhA DrugInfoLine. 

Copyright:
APhA DrugInfoLine (ISSN 1527-8530) is published monthly, and is owned and copyrighted by APhA. All material on pharmacist.com that is derived from APhA DrugInfoLine is copyrighted by APhA, and all rights are reserved by the Association. Materials in APhA DrugInfoLine do not necessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that information contained in APhA DrugInfoLine is accurate and current; however, they shall have no liability to any person or entity with regard to claims, losses, or damages caused or alleged to be caused, directly or indirectly, by use of any information contained in the publication. All decisions about drug therapy must be based on the independent judgment of the clinician.

Permissions and reprints:
For permission to copy or to request reprints, e-mail adil@aphanet.org.

Staff:

  • President: Winnie M. Landis, BPharm
  • Executive Vice President: John A. Gans, PharmD
  • Publisher: Frank Bennicasa
  • Editor: L. Michael Posey, BPharm (adil@aphanet.org)
  • Managing Editor: Carli Richard, MBA
  • Assistant Editors: Joseph Sheffer and Alex Egervary
  • Copy Editor: Bob Reynolds
  • Administrative/Publishing Coordinator: Kristin Hodges
  • Circulation Manager: Patricia J. Massenberg
  • Contributing Writers: Ellen Whipple Guthrie, PharmD, Bernie R. Olin, PharmD, and Maria G. Tanzi, PharmD
  • Director, Creative Services: Bill Succolosky

Editorial Advisory Board:

  • Omar Badawi, PharmD, BCPS, Assistant Professor of Pharmacy Practice, School of Pharmacy, University of Maryland, Baltimore
  • Amber L. Briggs, PharmD, Clinical Pharmacist/Pharmacy Consultant, Soldotna Professional Pharmacy, Soldotna, Alaska
  • Jack J. Chen, PharmD, BCPS, CGP, Associate Professor (Neurology), School of Pharmacy, and Clinical Associate Professor of Neurology, Movement Disorders Center, Loma Linda University, Loma Linda, Calif.
  • M. Lynn Crismon, PharmD, Professor and Associate Dean for Clinical Programs, College of Pharmacy, University of Texas at Austin, Austin
  • Devra K. Dang, PharmD, Assistant Clinical Professor, School of Pharmacy, University of Connecticut, Storrs, and Clinical Pharmacy Specialist, University of Connecticut/St. Francis Primary Care Center at Burgdorf Health Center, Hartford
  • Betty J. Dong, PharmD, Professor of Clinical Pharmacy and Family and Community Medicine, Schools of Pharmacy and Medicine, University of California, San Francisco
  • Edward F. Foote, PharmD, FCCP, BCPS, Associate Professor and Chair, Department of Pharmacy Practice, Nesbit College of Pharmacy and Nursing, Wilkes University, Wilkes-Barre, Pa.
  • John D. Grabenstein, PhD, COL, FAPhA, Military Vaccine Agency, US Army Medical Command, Falls Church, Va.
  • Nicole M. Maisch, PharmD, Assistant Clinical Professor, College of Pharmacy and Allied Health Professions, St. John’s University, Queens, N.Y., and Assistant Director, Drug Information Service, Long Island Jewish Medical Center, New Hyde Park, N.Y.
  • Frank Pucino, PharmD, BCPS, FASHP, FDPGEC, Ambulatory Care Clinical Pharmacy Team Leader, Pharmacy Department, National Institutes of Health, Bethesda, Md.
  • Charles D. Ponte, PharmD, CDE, BCPS,BC-ADM, Professor of Clinical Pharmacy and Family Medicine, Schools of Pharmacy and Medicine, Robert C. Byrd Health Sciences Center of West Virginia University, Morgantown
  • Sarah Ray, PharmD, BCPS, Clinical Coordinator and Residency Program Director, Ambulatory Care Services, Department of Pharmaceutical Services, Aurora Health Care, Milwaukee, Wis.
  • Arthur A. Schuna, MS, FASHP, Clinical Pharmacy Coordinator, William S. Middleton VA Medical Center, and Clinical Professor, School of Pharmacy, University of Wisconsin, Madison
  • R. William Soller, PhD, Executive Director, Center for Consumer Self Care, and Clinical Professor of Pharmacy, University of California, San Francisco
  • Daniel S. Streetman, PharmD, MS, Clinical Assistant Professor, Assistant Research Scientist, and Head, Clinical Pharmacogenomics Laboratory, College of Pharmacy, University of Michigan, Ann Arbor
  • C. Wayne Weart, PharmD, BCPS, FASHP, Professor of Pharmacy Practice, College of Pharmacy, Medical University of South Carolina, Charleston
  • Gary C. Yee, PharmD, FCCP, Professor and Chair of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center, Omaha

Questions/Comments

If you have questions or comments regarding content or editorial management, please contact:

APhA DrugInfoLine
1100 15th Street, NW
Suite 400
Washington, DC 20005
(202) 429-7557; (202) 628-5425 (fax);
adil@aphanet.org